Abstract:Background:Human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) is currently rising in incidence; however, a noninvasive approach to predicting HPV status that strongly correlates with p16 expression is lacking. This study aimed to develop a radiomics model based on multisequence magnetic resonance imaging (MRI) of primary tumor (PT) and lymph node (LN)-fused imaging features for the prediction of p16 status in OPSCC.Methods:In this retrospective study, 141 patients (comprising 116 patients in the training cohort and 25 patients in the testing cohort) with histopathologically confirmed (OPSCC) were enrolled consecutively from Fudan University Shanghai Cancer Center and Shanghai Ninth People's Hospital between January 2011 and December 2020. HPV status was determined by p16 immunohistochemistry analysis. A total of 2092 radiomics features were initially computed and extracted from the 3D-segmented PT and largest LN based on contrast-enhanced T1-weighted imaging (CE-T1WI) and T2-weighted imaging (T2WI). A support vector machine classifier was employed to build the machine learning-based classification models dependent on p16 status. The models were validated in the testing cohort. The area under the receiver operating characteristic curve (AUC) was computed to assess the performance of each model. This diagnostic study was not registered on the clinical trial platform.Results:In the testing cohort, fusion models yielded better performance (AUC) compared with models based on a sole PT/LN [CE-T1WI: 0.80 (95% CI: 0.55-0.94) vs. 0.71 (95% CI: 0.47-0.88)/0.73 (95% CI: 0.48-0.90); T2WI: 0.74 (95% CI: 0.51-0.95) vs. 0.64 (95% CI: 0.38-0.85)/0.71 (95% CI: 0.48-0.88)]. Models based on multisequence imaging outperformed single CE-T1WI/T2WI models [PT: 0.74 (95% CI: 0.46-0.91) vs. 0.71 (95% CI: 0.47-0.88)/0.64 (95% CI: 0.38-0.85); LN: 0.78 (95% CI: 0.55-0.75) vs. 0.73 (95% CI: 0.48-0.90)/0.71 (95% CI: 0.48-0.88)]. Finally, the PT-LN fusion model based on multisequencing yielded the best classification performance with the highest AUC value of 0.91 (95% CI: 0.72-0.98) for the prediction of p16 expression. The differences between the performance of the final model and the other 8 models were significant (all P values <0.05).Conclusions:The results demonstrated that (I) the PT-LN fusion radiomics models improved the classification performance of the sole use of PT or LN for the prediction of p16 status, (II) the radiomics models based on multisequences outperformed the single-sequence models in the prediction of p16 status, and (III) the PT-LN fusion model based on multisequence MRI radiomics features could serve as a noninvasive method for acquiring the molecular information of patients with OPSCC, potentially assisting oncologists with their clinical decision-making.

A Novel Prediction Model for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Using P16 and Subcellular Β-Catenin Expression.

P16INK4A As a Surrogate Biomarker for Human Papillomavirus-Associated Oropharyngeal Carcinoma: Consideration of Some Aspects.

Differential molecular characterization of human papillomavirus‐associated oropharyngeal squamous cell carcinoma and its prognostic value

Applying Multisequence MRI Radiomics of the Primary Tumor and Lymph Node to Predict HPV-related P16 Status in Patients with Oropharyngeal Squamous Cell Carcinoma.

Evaluation of P16 As a Surrogate Marker for Transcriptionally Active Human Papillomavirus Status of Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.

Identification of Potential Prognostic Biomarkers in Vulval Squamous Cell Carcinoma Based on Human Papillomavirus Infection Status-Analysis of GSE183454

Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population

Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region

Human papillomavirus infection and prognostic predictors in patients with oropharyngeal squamous cell carcinoma.

[Relationship Between HPV-DNA Status and P16 Protein Expression in Oropharyngeal Squamous Cell Carcinoma and Their Clinical Significance].

Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patients

[Evaluation of p16/Ki-67 double-stained immunohistochemistry in diagnosis of human papilloma virus-positive oropharyngeal squamous cell carcinoma].

TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma

Relationship between p16 expression and prognosis in different anatomic subsites of OSCC

Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.

Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma

p16 overexpression and Rb loss correlate with high‐risk HPV infection in oropharyngeal squamous cell carcinoma

Prognostic significance of cyclin D1 expression pattern in HPV-negative oral and oropharyngeal carcinoma: A deep-learning approach

A Prognostic Scoring Model Based on the HPV Status of Oropharyngeal Carcinoma Patients Treated with Postoperative Radiotherapy in China.

Analysis of clinicopathological features of human papilloma virus-associated oropharyngeal squamous cell carcinoma

[Human Papillomavirus Infection in Oropharyngeal Squamous Cell Carcinoma and Prognosis: a Preliminary Analysis of 66 Cases].